Dopamine depresses minute ventilation in patients with heart failure

Circulation

Volumn 98, Issue 2, 1998, Pages 126-

  Van De Borne, Philippe ^a   Oren, Ron ^a   Somers, Virend K ^a,b  

^a UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

Dopamine; Heart failure; Nervous system, sympathetic; Ventilation

Indexed keywords

DOPAMINE;

ADULT; AGED; ARTICLE; CHEMORECEPTOR REFLEX; CLINICAL ARTICLE; DOSE RESPONSE; DRUG EFFECT; FEMALE; HEART FAILURE; HUMAN; HYPOXIA; LUNG MINUTE VOLUME; MALE; OXYGEN SATURATION; PRIORITY JOURNAL; SYMPATHETIC TONE;

EID: 0345019900     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.98.2.126     Document Type: Article

References (27)

1. Somers VK, Zavala DC, Mark AL, Abboud FM. Influence of ventilation and hypocapnia on sympathetic nerve responses to hypoxia in normal humans. J Appl Physiol. 1989;67:2095-2100.
2. Somers VK, Zavala DC, Mark AL, Abboud FM. Contrasting effects of hypoxia and hypercapnia on ventilation and sympathetic activity in humans. J Appl Physiol. 1989;67:2101-2106.
3. Niemi M, Ojala K. Cytochemical demonstration of catecholamines in the human carotid body. Nature (Lond). 1964;203:539-540.
4. Chiocchio SR, Biscardi AM, Tramezzani JH. Catecholamines in the carotid body of the cat. Nature (Lond). 1966;212:834-835.
5. Black AMS, Comroe JH Jr, Jacobs L. Species difference in carotid body response of cat and dog to dopamine and serotonin. Am J Physiol. 1972;223:1097-1102.
6. Welsh MJ, Heistad DD, Abboud FM. Depression of ventilation by dopamine in man: evidence for an effect on the chemoreceptor reflex. J Clin Invest. 1978;61:708-713.
7. Bascom DA, Clement ID, Dorrington KL, Robbins PA. Effects of dopamine and domperidone on ventilation during isocapnic hypoxia in humans. Respir Physiol. 1991;86:319-328.
8. Bizgard GE, Kressin NA, Nielsen AM, Daristotle L, Smith CA, Forster HV. Dopamine blockage alters ventilatory acclimatization to hypoxia in goats. Respir Physiol. 1987;69:245-255.
9. Girbes AR, Smit AJ. Use of dopamine in the ICU: hope, hype, belief and facts. Clin Exp Hypertens. 1997;19:191-199.
10. Parker S, Carrlon GC, Isaacs M, Howland WS, Kahn RC. Dopamine administration in oliguria and oliguric renal failure. Crit Care Med. 1981;9:630-632.
11. Goldberg LI. Dopamine: clinical use of an endogenous catecholamine. N Engl J Med. 1974;291:707-710.
12. Baldwin L, Henderson A, Hickman P. Effect of postoperative low dose dopamine on renal function after elective major vascular surgery. Ann Intern Med. 1994;120:744-747.
13. Myles PS, Buckland MR, Schenk NJ, Cannon GB, Langley M, David BB, Weeks AM. Effect of "renal-dose" dopamine on renal function following cardiac surgery. Anaesth Intensive Care. 1993;21:56-61.
14. Swygert TH, Robert LC, Valek TR, Brajtbord B, Brown MR, Gunning TC, Paulsen AW, Ramsay MA. Effect of intraoperative low-dose dopamine on renal function in liver transplant recipients. Anesthesiology. 1991;75:571-576.
15. Flancbaum L, Choban P, Dasta J. Quantitative effects of low-dose dopamine on urine output in oliguric surgical intensive care unit patients. Crit Care Med. 1994;22:61-66.
16. Varriale P, Mossavi A. The benefit of low-dose dopamine during vigorous diuresis for congestive heart failure associated with renal insufficiency: does it protect renal function? Clin Cardiol. 1997;20:627-630.
17. David RF, Lappas DG, Kirklin JK, Buckley MJ, Lowenstein E. Acute oliguria after cardiopulmonary bypass: renal functional improvement with low-dose dopamine infusion. Crit Care Med. 1982;10:852-856.
18. Novikov GA, Eremenko AA. Methodologic approach to the discontinuation of long-term artifical ventilation in cardiosurgical patients with postoperative cardiac insufficiency. Anesteziol Reanimatol. 1990;2:9-12.
19. van Veldhuisen DJ, Brouwer J, Veld AJM, Dunselman PHJM, Boomsma F, Lie KI. Progression of mild untreated heart failure during six months follow-up and clinical and neurohumoral effects of ibopamine and digoxin as monotherapy. Am J Cardiol. 1995;75:796-800.
20. Vallbo AB, Hagbarth K-E, Torebjork HE, Wallin BG. Somatosensory, proprioceptive, and sympathetic activity in human peripheral nerves. Physiol Rev. 1979;59:919-957.
21. Wallin G. Intraneural recording and autonomic function in man. In: Bannister R, ed. Autonomic Failure. London, UK: Oxford University Press; 1983:36-51.
22. Huckauf H, Ramdohr B, Schroder R. Dopamine induced hypoxemia in patients with left heart failure. Int J Clin Pharmacol. 1976;14:217-224.
23. Goldberg LI. Cardiovascular and renal action of dopamine: potential clinical applications. Pharmacol Rev. 1972;24:1-29.
24. Chua TP, Clark AL, Amadi AA, Coats AJ. Relation between chemosensitivity and ventilatory response to exercise in chronic heart failure. J Am Coll Cardiol. 1996;27:650-657.
25. Frishman WH, Hotchkiss H. Selective and nonselective dopamine receptor agonists: an innovative approach to cardiovascular disease treatment. Am Heart J. 1996;132:861-870.
26. Hampton JR, van Veldhuisen DJ, Kleber FX, Cowley AJ, Ardia A, Block P, Cortina A, Cserhalmi L, Follath F, Jensen G, Kayanakis J, Lie KI, Mancia G, Skene AM. Randomised study of effect of ibopamine on survival in patients with advanced severe heart failure. Lancet. 1997;349:971-977.
27. Niebauer J, Coats AJS. Treating chronic heart failure: time to take stock. Lancet. 1997;349:966-967. Commentary.